NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-89

  1. 13,012 Posts.
    lightbulb Created with Sketch. 778
    88888acct: Simply a brilliant post by you. Many THANKS for this.

    wasa

    PS: If/when I can free-up some more funds, will surely buy some more NEU.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.